• Resumption of growth in Q3 for the Medical branch, stability for the Photonics branch
• Signature of an agreement with Amplitude Laser Group to acquire the Continuum range of nanosecond lasers from its American subsidiary,
The LUMIBIRD Group (FR0000038242 – LBIRD), European leader in laser technologies, recorded revenue of €141.5 million for the first 9 months of 2024, up +2% and stable at constant scope and exchange rates. Activity for the 3rd quarter shows a clear resumption of growth for the Medical branch, at +8.0% and stability for the Photonics branch, at +0.2% as published variation. The Group also announces the signing of an agreement with Amplitude Laser Group relating to the acquisition of the Continuum nanosecond laser product line, allowing Lumibird to enrich its range for scientific markets and strengthen its market leadership. North Americans.
Consolidated turnover (unaudited)
Revenue (M€) 2024 2023 Variation as published Variation at constant scope and exchange rates
1st quarter 43.9 40.9 +7% +5%
2nd quarter 54.1 56.3 -4% -7%
3rd quarter 43.5 41.8 +4% +4%
9 months 141.5 139.0 +2% 0%
dont
Photonics 67.3 65.9 +2% -3%
Medical 74.2 73.0 +2% +3%
